We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Can NuScale Turn Its Regulatory Lead Into Commercial Success?
Read MoreHide Full Article
Key Takeaways
SMR enters commercialization with approved reactor designs, a supply chain and about $1 billion in liquidity.
The TVA-ENTRA1 plan could add up to 6 GW, but revenue hinges on a finalized power-purchase agreement.
Funding delays and equity sales could defer module revenue and increase shareholder dilution.
NuScale Power Corporation (SMR - Free Report) is entering a pivotal commercialization phase with regulatory approvals, an established supply chain and sizable liquidity already in place.
The next test is harder. NuScale must convert development programs into binding contracts, recurring service revenue and equipment sales before its long-term nuclear opportunity can support a larger revenue base.
NuScale’s Regulatory Lead Shapes the Bull Case
NuScale’s strongest advantage is regulatory. Its 50-megawatt and 77-megawatt reactor designs have received U.S. regulatory approval, giving potential customers an approved design path for plant applications.
The technology is based on familiar light-water reactors and commercially available low-enriched uranium fuel. Its safety case also supports an emergency planning zone largely limited to the plant site, which may improve siting flexibility for utilities, data centers and industrial users.
That positioning matters in a competitive nuclear market. BWX Technologies (BWXT - Free Report) offers investors a nuclear-components reference point, while Oklo Inc. (OKLO - Free Report) represents another advanced-reactor developer. NuScale’s appeal rests on having already cleared important U.S. design hurdles.
SMR’s TVA Path Could Transform Revenue
The proposed Tennessee Valley Authority and ENTRA1 Energy program is NuScale’s most visible U.S. commercial opportunity. The plan covers up to 6 gigawatts of capacity using NuScale modules across multiple plants.
Image Source: NuScale Power Corporation
A finalized power-purchase agreement could move the program into site-specific licensing and engineering work. Over time, it could also support an equipment supply contract, creating a bridge from limited current revenue to larger commercial activity.
NuScale reported first-quarter revenues of $565,000, down from $13.4 million a year earlier as prior RoPower licensing and engineering activity did not recur. That makes the timing of new service work important before larger module-related payments begin.
NuScale’s Liquidity Buys Time for Execution
NuScale ended the first quarter with about $1 billion in liquidity and capital resources, including cash, short-term investments and long-term investments. It also had no debt, giving the company room to prepare for deployment without relying heavily on borrowing.
Image Source: NuScale Power Corporation
That capital cushion can support supplier commitments, design work, licensing activity and long-lead materials. These investments are necessary because nuclear projects require work well before major customer payments arrive.
Liquidity does not remove execution risk. It does, however, give NuScale more time to align suppliers, prepare manufacturing and support customers as projects move through financing and approval stages.
SMR’s Funding and Dilution Risks Stay Elevated
The central obstacle remains project funding. NuScale depends on customers and partners securing financing before construction, equipment orders and long-term commercial agreements can move ahead.
Delays could postpone service revenue and module sales while NuScale continues spending on commercialization. Research and development expenses rose in the first quarter as the company worked to advance technology readiness and design maturity.
Shareholder dilution is another concern. NuScale sold 3.2 million Class A shares through its at-the-market program in the first quarter, generating $37.9 million in gross proceeds, after a larger equity raise in 2025.
SMR’s Signals Reflect a Mixed Near-Term Setup
The bottom line is that NuScale has a credible long-term commercialization case, but the near-term setup remains mixed. Its regulatory lead and liquidity are meaningful advantages, while revenue visibility still depends on contract conversion and project sequencing.
SMR currently carries a Zacks Rank #4 (Sell). That rank points to a cautious near-term earnings revision backdrop, even though the company’s commercial pipeline could become more important over a longer horizon.
The stock’s Momentum Score of B indicates comparatively better price-related characteristics. However, the Value Score of F, Growth Score of F and VGM Score of F are less favorable, reinforcing a cautious view until NuScale shows clearer progress in turning approvals and development programs into recurring revenues and equipment sales.
View the Zacks #1 Rank List
Image: Bigstock
Can NuScale Turn Its Regulatory Lead Into Commercial Success?
Key Takeaways
NuScale Power Corporation (SMR - Free Report) is entering a pivotal commercialization phase with regulatory approvals, an established supply chain and sizable liquidity already in place.
The next test is harder. NuScale must convert development programs into binding contracts, recurring service revenue and equipment sales before its long-term nuclear opportunity can support a larger revenue base.
NuScale’s Regulatory Lead Shapes the Bull Case
NuScale’s strongest advantage is regulatory. Its 50-megawatt and 77-megawatt reactor designs have received U.S. regulatory approval, giving potential customers an approved design path for plant applications.
The technology is based on familiar light-water reactors and commercially available low-enriched uranium fuel. Its safety case also supports an emergency planning zone largely limited to the plant site, which may improve siting flexibility for utilities, data centers and industrial users.
That positioning matters in a competitive nuclear market. BWX Technologies (BWXT - Free Report) offers investors a nuclear-components reference point, while Oklo Inc. (OKLO - Free Report) represents another advanced-reactor developer. NuScale’s appeal rests on having already cleared important U.S. design hurdles.
SMR’s TVA Path Could Transform Revenue
The proposed Tennessee Valley Authority and ENTRA1 Energy program is NuScale’s most visible U.S. commercial opportunity. The plan covers up to 6 gigawatts of capacity using NuScale modules across multiple plants.
A finalized power-purchase agreement could move the program into site-specific licensing and engineering work. Over time, it could also support an equipment supply contract, creating a bridge from limited current revenue to larger commercial activity.
NuScale reported first-quarter revenues of $565,000, down from $13.4 million a year earlier as prior RoPower licensing and engineering activity did not recur. That makes the timing of new service work important before larger module-related payments begin.
NuScale’s Liquidity Buys Time for Execution
NuScale ended the first quarter with about $1 billion in liquidity and capital resources, including cash, short-term investments and long-term investments. It also had no debt, giving the company room to prepare for deployment without relying heavily on borrowing.
That capital cushion can support supplier commitments, design work, licensing activity and long-lead materials. These investments are necessary because nuclear projects require work well before major customer payments arrive.
Liquidity does not remove execution risk. It does, however, give NuScale more time to align suppliers, prepare manufacturing and support customers as projects move through financing and approval stages.
SMR’s Funding and Dilution Risks Stay Elevated
The central obstacle remains project funding. NuScale depends on customers and partners securing financing before construction, equipment orders and long-term commercial agreements can move ahead.
Delays could postpone service revenue and module sales while NuScale continues spending on commercialization. Research and development expenses rose in the first quarter as the company worked to advance technology readiness and design maturity.
Shareholder dilution is another concern. NuScale sold 3.2 million Class A shares through its at-the-market program in the first quarter, generating $37.9 million in gross proceeds, after a larger equity raise in 2025.
SMR’s Signals Reflect a Mixed Near-Term Setup
The bottom line is that NuScale has a credible long-term commercialization case, but the near-term setup remains mixed. Its regulatory lead and liquidity are meaningful advantages, while revenue visibility still depends on contract conversion and project sequencing.
SMR currently carries a Zacks Rank #4 (Sell). That rank points to a cautious near-term earnings revision backdrop, even though the company’s commercial pipeline could become more important over a longer horizon.
You can see the complete list of today’s Zacks #1 Rank stocks here.
The stock’s Momentum Score of B indicates comparatively better price-related characteristics. However, the Value Score of F, Growth Score of F and VGM Score of F are less favorable, reinforcing a cautious view until NuScale shows clearer progress in turning approvals and development programs into recurring revenues and equipment sales.